⚡ The Discord is Back as THOR TRADERS! ⚡
A trading community built for Stocks & Crypto! 📈₿
Bring your plays, share charts, discuss setups, catalysts, and market moves with fellow traders.
🔨 Join Thor Traders today 👉 https://t.co/Iroi58rEVd
#discord#stocks#Crypto
$COSM Cosmos Health Provides U.S. E-Commerce Update for October 2026: Monthly Subscription Value Reaches $1.83 Million, Approximately $22 Million Annualized
~ Monthly subscription value of $1.83 million as of October 31, 2026, approximately $22.0 million on an annualized basis
~ 12,532 active U.S. subscriptions as of October 31, 2026
~ October U.S. e-commerce total sales of $1.67 million, of which approximately $1.02 million, or 61%, was attributable to subscriptions
~ Approximately 19,100 orders in October from approximately 234,500 online store sessions
~ Continued momentum in November, with U.S. e-commerce sales continuing to grow significantly
CHICAGO, IL / ACCESS Newswire / November 11, 2026 / Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its U.S. direct-to-consumer subscription business reached $1,832,785 in monthly subscription value as of October 31, 2026, equivalent to approximately $22.0 million on an annualized basis. In October 2026, the Company's U.S. e-commerce business recorded total sales of $1,673,004, of which $1,015,231 was attributable to subscriptions.
Building a Recurring Revenue Base
Cosmos Health launched its U.S. subscription model in mid-July 2026 and began scaling it in mid-September. The Company's products are sold through its own online stores directly to customers, who can choose a subscription for recurring delivery at checkout. Active subscriptions renew on a recurring basis, so every new subscriber can represent an ongoing customer relationship rather than a single sale.
Outlook for the Fourth Quarter
The Company has allocated an increased marketing budget to continue scaling its U.S. direct-to-consumer sales through the fourth quarter of 2026, including the holiday shopping season. Cosmos Health plans to expand digital customer acquisition, grow its subscription base and introduce additional products from its portfolio to its U.S. online stores. Momentum has continued into November, with U.S. e-commerce sales continuing to grow significantly.
Greg Siokas, CEO of Cosmos Health, stated: "Since we began scaling our U.S. subscription platform in mid-September, we have built a subscription business with $1.83 million in monthly subscription value, or approximately $22 million on an annualized basis. As of October 31, more than 12,500 subscriptions were active, with an average of approximately 2.4 products per subscription.
"We believe recurring revenue is among the most valuable revenue a consumer health company can build, and we plan to continue scaling our U.S. direct-to-consumer business through the fourth quarter and beyond."
About Cosmos Health Inc.
Cosmos Health Inc. (NASDAQ:COSM), incorporated in 2009 in Nevada, is a diversified, vertically integrated global healthcare group. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept® and C-Scrub®. Through its subsidiary Cana Laboratories S.A., licensed under European Good Manufacturing Practices (GMP) and certified by the European Medicines Agency (EMA), it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. Cosmos Health also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and OTC medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the UK. Furthermore, the Company has established R&D partnerships targeting major health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of novel patented nutraceuticals, specialized root extracts, proprietary complex generics, and innovative OTC products. Cosmos Health has also entered the telehealth space through the acquisition of ZipDoctor, Inc., based in Texas, USA. With a global distribution platform, the Company is currently expanding throughout Europe, Asia, and North America, and has offices and distribution centers in Thessaloniki and Athens, Greece, and in Harlow, UK.
.@BuxtonResources Managing Director Martin Moloney commented on the commencement of maiden diamond drilling at the Wolverine Copper-Molybdenum Project in Arizona.
#ASX#BUX#Mining
$LKY.ax | $LKYRF Locksley Resources: Our Exploration Licence EL9969 “Tottenham West” has been granted, adding 139 km² to the Locksley Resources tenement position. #Exploration#NSW#ASX#LKY
VisionWave Holdings, Inc.
Nasdaq: $VWAV
VisionWave has outlined its dual-use technology strategy to expand autonomous platforms into commercial markets.
The company is leveraging technologies developed for defense, such as its Solar Drone aerial-maintenance systems, to support potential applications in infrastructure, agriculture, and aviation. These commercial initiatives aim to create additional scale and accelerate product iteration for the company's core sensing and intelligence architectures.
Further updates on commercial deployments are expected in 2026.
Read more: https://t.co/b6zT2rvRZv
#DefenseTech #VWAV
#AD – Paid Dissemination
Bitcoin Bancorp, Inc.
OTC: $BCBC
Bitcoin Bancorp has formally submitted a public comment to the U.S. Securities and Exchange Commission regarding the regulation of tokenized National Market System stocks.
The company advocates for function-based rules that distinguish between securities trading intermediaries and independent technology providers that support identity verification and compliance. This submission responds to the SEC's recent order granting temporary conditional exemptions for tokenized stock trading activities.
Management expects these clearer infrastructure distinctions to support broader retail participation in tokenized financial markets as regulatory frameworks continue to evolve.
Read more: https://t.co/WEZ4jKyj4w
#Fintech #Tokenization #BCBC
#AD – Paid Dissemination
⚡ The Discord is Back as THOR TRADERS! ⚡
A trading community built for Stocks & Crypto! 📈₿
Bring your plays, share charts, discuss setups, catalysts, and market moves with fellow traders.
🔨 Join Thor Traders today 👉 https://t.co/Iroi58rEVd
#discord#stocks#Crypto
$IQST Record Revenue, Strategic Acquisitions, and High-Margin Expansion: The Investment Case for (NASDAQ: IQST)
Full Details Here: https://t.co/4m810I0bq9
#OTC#thursday
$ECDP Many Reasons To Like ECDP Here!
~ Subsidiary, CCT to finalize a 40% participation share in an initial $100M dredging contract for #Mexico's Punta Colonet Megaport Project!
~ $40 MILLION projected for #ECDP's subsidiary CCT
~ Gross profit: ~$2.15M (1st 6mo 2026) Net income: $1.14M
~ Strong cash position - Cash and cash equivalents: $756,772 (as of June 30, 2026)
~ Total assets $82.9M
~ Book value per share is roughly in the ~$0.20 range (depending on shares outstanding).
~ Strong add-on revenue potential and larger projects on deck
~ Small Float: Nearly 79% of outstanding shares are restricted
~ Hiring new accounting firm for SEC compliance
~ Seeking to uplist to a higher OTC tier
~ Real Operating Subsidiary with Prior Project History
$ECDP Many Reasons To Like ECDP Here!
~ Subsidiary, CCT to finalize a 40% participation share in an initial $100M dredging contract for #Mexico's Punta Colonet Megaport Project!
~ $40 MILLION projected for #ECDP's subsidiary CCT
~ Gross profit: ~$2.15M (1st 6mo 2026) Net income: $1.14M
~ Strong cash position - Cash and cash equivalents: $756,772 (as of June 30, 2026)
~ Total assets $82.9M
~ Book value per share is roughly in the ~$0.20 range (depending on shares outstanding).
~ Strong add-on revenue potential and larger projects on deck
~ Small Float: Nearly 79% of outstanding shares are restricted
~ Hiring new accounting firm for SEC compliance
~ Seeking to uplist to a higher OTC tier
~ Real Operating Subsidiary with Prior Project History
$IQST ✨ Upcoming Catalyst: Ultranet Deal Closing Soon! The Ultranet Acquisition Will Add Approximately $131 Million In Annual Revenue For IQSTEL Inc.
#Stocks#TechStocks